4.1. Revised Risk Index Based on Primary Aberrations Characterized the Prognosis of 30% of ALL Patients; Rationale for Further Stratification of NEG and BCR::ABL1pos Subgroups. This evidence concerns the gene BCR and acute lymphoblastic leukemia.